140 related articles for article (PubMed ID: 11494787)
1. Stability of Adderall in extemporaneously compounded oral liquids.
Justice J; Kupiec TC; Matthews P; Cardona P
Am J Health Syst Pharm; 2001 Aug; 58(15):1418-21. PubMed ID: 11494787
[TBL] [Abstract][Full Text] [Related]
2. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
3. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
[TBL] [Abstract][Full Text] [Related]
4. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1998 Sep; 55(18):1915-20. PubMed ID: 9784772
[TBL] [Abstract][Full Text] [Related]
5. Stability of extemporaneously prepared moxifloxacin oral suspensions.
Hutchinson DJ; Johnson CE; Klein KC
Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
[TBL] [Abstract][Full Text] [Related]
6. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP; Johnson CE; Sudekum D; Penprase K
Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
[TBL] [Abstract][Full Text] [Related]
7. Stability of extemporaneously prepared cinacalcet oral suspensions.
Thomson K; Hutchinson DJ; Chablani L
Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
[TBL] [Abstract][Full Text] [Related]
8. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
Cober MP; Johnson CE
Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
[TBL] [Abstract][Full Text] [Related]
9. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
[TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE; Cober MP; Hawkins KA; Julian JD
Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
[TBL] [Abstract][Full Text] [Related]
11. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
[TBL] [Abstract][Full Text] [Related]
12. Stability of extemporaneously prepared rufinamide oral suspensions.
Hutchinson DJ; Liou Y; Best R; Zhao F
Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
[TBL] [Abstract][Full Text] [Related]
13. Stability of two concentrations of tiagabine in an extemporaneously compounded suspension.
Haase MR; Khan MA; Bonilla J
Int J Pharm Compd; 2003; 7(6):485-9. PubMed ID: 23979810
[TBL] [Abstract][Full Text] [Related]
14. Stability of rifabutin in two extemporaneously compounded oral liquids.
Haslam JL; Egodage KL; Chen Y; Rajewski RA; Stella V
Am J Health Syst Pharm; 1999 Feb; 56(4):333-6. PubMed ID: 10690216
[TBL] [Abstract][Full Text] [Related]
15. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
Nahata MC; Morosco RS; Hipple TF
Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
[TBL] [Abstract][Full Text] [Related]
16. Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP; Johnson CE; Lee J; Currie K
Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide stability in extemporaneously compounded oral suspensions.
Trissel LA; Zhang Y; Koontz SE
Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
[TBL] [Abstract][Full Text] [Related]
18. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
[TBL] [Abstract][Full Text] [Related]
19. Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children.
Pramann LA; Davidow LW; van Haandel L; Funk RS
Int J Pharm Compd; 2016; 20(3):257-261. PubMed ID: 28333668
[TBL] [Abstract][Full Text] [Related]
20. Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Oct; 53(19):2304-9. PubMed ID: 8893069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
